{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:10:36Z","timestamp":1780629036473,"version":"3.54.1"},"reference-count":52,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Hosp Palliat Care"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Antidepressants can be used to manage symptoms at the end of life, but the dying process can impact their use.\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To examine the use of antidepressants during hospice patients\u2019 final months of home care.\n                    <jats:bold>Methods:<\/jats:bold>\n                    A retrospective case records review of 227 hospice patients in their last three months of care in a residential setting. Chart reviews were conducted of medication logs, hospice staff notes, and caregiver narratives to examine antidepressant use including types of medications prescribed and factors associated with medication maintenance.\n                    <jats:bold>Results:<\/jats:bold>\n                    Thirty percent of patients were prescribed at least 1 antidepressant for symptoms including depression, anxiety, pain, disturbances in sleep, and poor appetite. The majority (96.1%) of patients were not administered their antidepressant on the day of death, and more than half (61.8%) did not receive their antidepressant during their last 3\u00a0days of life. A quarter (25.5%) of patients on antidepressants did not receive medication 4-7\u00a0days prior to death while some (12.7%) went without their antidepressant for 8 or more days. Antidepressant use was discontinued by hospice staff or caregivers due to a variety of reasons including difficulty swallowing, minimal consciousness, confusion, nausea, or patient refusal.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Antidepressants are prescribed to manage multiple symptoms at the end of life, but use is often disrupted during patients' final days. Tapering and other prescription adjustments may be warranted to avoid risk of antidepressant discontinuation syndrome (ADS).\n                  <\/jats:p>","DOI":"10.1177\/10499091221134028","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T01:38:05Z","timestamp":1665797885000},"page":"953-958","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Antidepressant Use During Hospice Patients\u2019 Final Months on Routine Home Care"],"prefix":"10.1177","volume":"40","author":[{"given":"Erika","family":"Crampton","sequence":"first","affiliation":[{"name":"MGH Institute of Health Professions"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol S.","family":"Weisse","sequence":"additional","affiliation":[{"name":"Union College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Hospice Facts and Figures","year":"2020","unstructured":"2020 Edition: Hospice Facts and Figures. Alexandria, VA: National Hospice and Palliative Care Organization. 2020. www.nhpco.org\/factsfigures"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1191\/02169216302pm507oa"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.10.015"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2747-0"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0529-7"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.15.1849"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1191\/0269216304pm923oa"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216310380764"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.05.023"},{"issue":"1","key":"e_1_3_3_11_2","first-page":"30","article-title":"Antidepressants as analgesics: a review of randomized controlled trials","volume":"26","author":"Lynch ME","year":"2001","unstructured":"Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci. 2001;26(1):30-36.","journal-title":"J Psychiatry Neurosci"},{"issue":"12","key":"e_1_3_3_12_2","first-page":"16","article-title":"Pain, pain, go away: antidepressants and pain management","volume":"5","author":"Sansone RA","year":"2008","unstructured":"Sansone RA, Sansone LA. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont). 2008;5(12):16-19. PMID: 19724772; PMCID: PMC2729622.","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X17666190811161807"},{"issue":"4","key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/154733251903100413","article-title":"Antidepressants for anxiety disorders in late-life: a systematic review","volume":"31","author":"Balasubramaniam M","year":"2019","unstructured":"Balasubramaniam M, Joshi P, Alag P, Gupta S, Maher S, Tampi D, et al. Antidepressants for anxiety disorders in late-life: a systematic review. Ann Clin Psychiatr. 2019;31(4):277-291. PMID: 31369663.","journal-title":"Ann Clin Psychiatr"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565070-00003"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0803-z"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2020915"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010753.pub2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7172"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2011-000024"},{"issue":"6","key":"e_1_3_3_21_2","first-page":"25","article-title":"Treating depression in terminally ill patients can optimize their physical comfort at the end of life and provide them the opportunity to confront and prepare for death","volume":"63","author":"Braun UK","year":"2008","unstructured":"Braun UK, Kunik ME, Pham C. Treating depression in terminally ill patients can optimize their physical comfort at the end of life and provide them the opportunity to confront and prepare for death. Geriatrics. 2008;63(6):25-27. PMID: 18512998.","journal-title":"Geriatrics"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi115"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.1.68"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0690(18)30230-1"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4551"},{"issue":"2","key":"e_1_3_3_26_2","first-page":"62","article-title":"Antidepressants in patients with advanced cancer: when they're warranted and how to choose therapy","volume":"33","author":"Ahmed E","year":"2019","unstructured":"Ahmed E. Antidepressants in patients with advanced cancer: when they're warranted and how to choose therapy. Oncology (Williston Park). 2019;33(2):62-68. PMID: 30784031.","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15320"},{"issue":"3","key":"e_1_3_3_28_2","first-page":"255","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria","volume":"25","author":"Black K","year":"2000","unstructured":"Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci. 2000;25(3):255-261. PMID: 10863885; PMCID: PMC1407715.","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0509b"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2017.0501"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7379.30"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmip.2019.01.002"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015583893"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/10499091221079618"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049909110385539"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1191\/026921699676753309"},{"issue":"76","key":"e_1_3_3_37_2","first-page":"1","article-title":"Antidepressant Use in Persons Aged 12 and over: United States, 2005-2008","author":"Pratt LA","year":"2011","unstructured":"Pratt LA, Brody DJ, Gu Q. Antidepressant Use in Persons Aged 12 and over: United States, 2005-2008. NCHS Data Brief. 2011(76):1-8. PMID: 22617183.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124030-00003"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v58n0702"},{"key":"e_1_3_3_40_2","first-page":"87+","article-title":"Liquid formulations: a practical alternative","volume":"9","author":"Prabhakar D","year":"2010","unstructured":"Prabhakar D, Balon R. Liquid formulations: a practical alternative. Current Psychiatry. 2010;9:87+. https:\/\/link.gale.com\/apps\/doc\/A259009893\/HRCA?u=nysl_ca_arg&sid=googleScholar&xid=ce053313","journal-title":"Current Psychiatry"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2018.0627"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015583893"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.04.012"},{"issue":"18","key":"e_1_3_3_44_2","first-page":"14","article-title":"Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea","volume":"64","author":"DeVane CL","year":"2003","unstructured":"DeVane CL. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J Clin Psychiatr. 2003;64(suppl 18):14-19. PMID: 14700450.","journal-title":"J Clin Psychiatr"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610207006047"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmu.2017.03.001"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2009.0048"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1191\/026921699675653923"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015060-00001"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2019.0355"},{"issue":"7","key":"e_1_3_3_51_2","first-page":"23","article-title":"Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel","volume":"58","author":"Schatzberg AF","year":"1997","unstructured":"Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, et al. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. J Clin Psychiatr. 1997;58(suppl 7):23-27.","journal-title":"J Clin Psychiatr"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3925438"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1992"}],"container-title":["American Journal of Hospice and Palliative Medicine\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10499091221134028","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10499091221134028","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10499091221134028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:29:37Z","timestamp":1777368577000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10499091221134028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1177\/10499091221134028"],"URL":"https:\/\/doi.org\/10.1177\/10499091221134028","relation":{},"ISSN":["1049-9091","1938-2715"],"issn-type":[{"value":"1049-9091","type":"print"},{"value":"1938-2715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}